If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Contract Win - Hotels

17 Jun 2005 07:00

XN Checkout Holdings PLC17 June 2005 Press Release 17 June 2005 XN Checkout Holdings plc Contract Win - Hotels Joint supply contract to provide Rocco Forte Hotels with Protel Multi-Property Edition PMS system XN Checkout Holdings Plc ("XN Checkout Holdings" or "the Company"), a marketleader of Electronic Point of Sale ("EPOS") solutions to the leisure, retail andhospitality markets, announces that it has won a significant new contract in thehotel industry. XN Checkout is part of the Protel Partnership consortium led by ProtelHotelsoftware GmbH (Dortmund, Germany) and Serenissima Informatica S.p.A.(Padua, Italy) which has been awarded a contract to supply all Rocco ForteHotels with the Protel Multi-Property Edition (MPE) PMS system. Rocco ForteHotels currently operates nine hotels throughout Europe with plans to open afurther four by the end of 2007. Sir Rocco Forte, Chairman of Rocco Forte Hotels, said: "Protel will provide thebackbone to our IT systems as we grow the company to a position of leadership inthe European luxury hotel market. Our hotels are already very skilled atremembering the preferences of our individual guests and anticipating theirneeds when they return. This enhanced IT backup will allow us to share thatknowledge such that guests of one of our hotels will be immediately recognisedwhen they visit other properties in the brand. We have chosen Protel because ofthe strength of their product, the competitive price and the high level ofcustomer service which they have demonstrated during our evaluation of theproducts in the marketplace." Earlier this year through its XN Australia Pty Limited subsidiary, the Companywon its first full-scale hotel contract in Australia with the Sydney-based Togahospitality group. For commercial reasons, the value of neither contract is being disclosed at thistime. Ed Dayan, Chief Executive Officer of XN Checkout Holdings plc, said: "We arevery proud to have been selected by Rocco Forte Hotels, who enjoy an enviablereputation for providing exceptional standards of luxury and customer care.This is a significant cross-border contract win and marks an extremely importantadvance for XN Checkout. The Protel product has powered not only our expansioninto the UK hotel industry, but also our entry into the Asian and Australasianmarkets. It is extremely encouraging that our own dotPOS system, which uses aVirtual Private Network model, is making inroads into the hotel market alongsideProtel. Our exclusive distribution rights for Protel in North America,Asia-Pacific and the United Kingdom present many opportunities for future growthof this division." The Directors would like to draw shareholders' attention to the announcementthat was issued on 10 June 2005 which referred to a Recommended Offer byEvolution Securities Limited on behalf of Torex Retail Plc for the entire sharecapital of XN Checkout Holdings Plc. For further information:XN Checkout Holdings PlcEd Dayan, Chief Executive +44 (0) 1582 869 600edayan@xncheckout.com www.xncheckout.com Daniel Stewart & Co.Ruari McGirr Tel: +44 (0) 20 7374 6789 www.danielstewart.co.uk Media enquiries:AbchurchHenry Harrison-Topham / Ariane Comstive Tel: +44 (0) 20 398 7700 henry.ht@abchurch-group.com www.abchurch-group.com Notes to editors XN Checkout Holdings plc XN Checkout is the market leader for EPOS hardware and software solutions intothe UK managed pub and bar sector, with over 4,000 systems installed. TheCompany has been successful in broadening its target markets to includerestaurants, hotels, retail shops and gaming hardware and software solutions. Co-founded in 1982 by the chief executive Ed Dayan, the Company created thefirst touch-till system for a pub and has over 20 years' experience ofmanufacturing hardware and developing software solutions for the EPOS market,resulting in XN Checkout technology remaining at the forefront of the industry.The Company's technology is now being used in the hotel, gaming, retail and thefast-growing SME hospitality sectors. As an innovator of web-based EPOS systems, XN Checkout benefits fromlong-standing client relationships with leading leisure and hospitalitybusinesses including Mitchells & Butlers, Wolverhampton & Dudley, the SpiritGroup, Young's and Stena Line. More recent customers include Cafe Rouge, TheParamount Group of Hotels, Caffe Nero and Gala Group. The Company employs 190people, is based in Dunstable, Bedfordshire and has offices in Singapore,Malaysia, South Korea, Australia, South Africa, the USA and Germany. For further information please visit www.xncheckout.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Nov 20227:00 amRNSDistribution agreement - OrthoPure® XT in Germany
14th Nov 20226:05 pmRNSHolding(s) in Company
7th Nov 20222:35 pmRNSHolding(s) in Company
29th Sep 202210:13 amRNSDirector/PDMR Shareholding
27th Sep 20227:15 amEQSHardman & Co Research on Tissue Regenix (TRX): Operating leverage
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20223:31 pmRNSHolding(s) in Company
18th Aug 20225:36 pmRNSHolding(s) in Company
18th Aug 20222:10 pmRNSHolding(s) in Company
11th Aug 20224:30 pmEQSHardman & Co Research: Q&A on Tissue Regenix Group plc: Significantly undervalued which should correct
11th Aug 202212:46 pmRNSHolding(s) in Company
11th Aug 202212:17 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSConfirmation of Interim Results
5th Aug 20223:19 pmRNSHolding(s) in Company
1st Aug 20223:14 pmRNSHolding(s) in Company
19th Jul 20222:30 pmEQSHardman & Co Research : Tissue Regenix (TRX): Strong 1H’22 sales suggest upside potential
19th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
18th Jul 20222:42 pmRNSHolding(s) in Company
18th Jul 20221:33 pmRNSHolding(s) in Company
15th Jul 20225:29 pmRNSHolding(s) in Company
27th Jun 20226:04 pmRNSHolding(s) in Company
27th Jun 202212:58 pmRNSHolding(s) in Company
16th Jun 20221:27 pmRNSExercise of Options and Total Voting Rights
28th Apr 20227:00 amRNSOrthoPure®XT clinical results presentation
26th Apr 20224:19 pmRNSResult of AGM
20th Apr 20224:26 pmRNSDirector/PDMR Shareholding
19th Apr 20227:15 amEQSHardman & Co Research: Tissue Regenix (TRX) On pathway to sustainability
8th Apr 20227:00 amRNSGrant of share options
6th Apr 20222:59 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSFinal year results for the year ended 31 Dec 2021
9th Mar 20227:00 amRNSDistribution agreement for OrthoPure® XT
2nd Mar 20227:00 amRNSNotice of Results
10th Feb 20223:45 pmRNSAdditional Director Disclosures
27th Jan 20227:00 amRNSFull Year Trading update
23rd Dec 20217:00 amRNSDirector/PDMR Shareholding
21st Dec 20212:06 pmRNSSecond Price Monitoring Extn
21st Dec 20212:01 pmRNSPrice Monitoring Extension
19th Oct 20211:15 pmEQSHardman & Co Research: Tissue Regenix (TRX): Faster-than-anticipated recovery
8th Oct 20217:00 amRNSHolding(s) in Company
5th Oct 20214:44 pmRNSHolding(s) in Company
28th Sep 20217:00 amRNSHolding(s) in Company
24th Sep 20212:05 pmRNSDirector/PDMR Shareholding
9th Sep 20214:35 pmRNSDirector/PDMR Shareholding
8th Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSLaunch of DermaPure® Meshed and VNEWTM
1st Sep 20217:00 amRNSNotice of Results
16th Aug 20217:00 amRNSHolding(s) in Company
14th Jul 20213:15 pmEQSHardman & Co Research: Q&A with Dr Martin Hall on Tissue Regenix Group Plc: New capacity now on stream
30th Jun 202111:56 amEQSHardman & Co Research: Tissue Regenix (TRX): Poised for growth
29th Jun 20211:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.